Literature DB >> 13590187

Experimental suppression of increased capillary permeability in thermal burns in rats.

W G SPECTOR, D A WILLOUGHBY.   

Abstract

Entities:  

Keywords:  ANTIHISTAMINICS/effects; BURNS/experimental; CAPILLARY PERMEABILITY/effect of drugs on; ISOFLUROPHATE/effects; SALICYLATES/effects

Mesh:

Substances:

Year:  1958        PMID: 13590187     DOI: 10.1038/182949a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

1.  SERUM AND PLASMA PROTEINS IN THERMALLY INJURED PATIENTS TREATED WITH PLASMA, ITS ADMIXTURE WITH ALBUMIN OR SERUM ALONE.

Authors:  S BAAR
Journal:  Ann Surg       Date:  1965-01       Impact factor: 12.969

2.  Vascular permeability changes in inflammation: the role of endogenous permeability factors in mild thermal injury.

Authors:  D L WILHELM; B MASON
Journal:  Br J Exp Pathol       Date:  1960-10

3.  Rationale of antihistaminic therapy in thermal injury; an experimental evaluation in the guinea-pig.

Authors:  D L WILHELM; B MASON
Journal:  Br Med J       Date:  1958-11-08

4.  Professor Derek Albert Willoughby (1930-2004).

Authors:  K D Rainsford
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

5.  The site of vascular response to thermal injury in skeletal muscle.

Authors:  F R Wells
Journal:  Br J Exp Pathol       Date:  1971-06

6.  Neutrophil Accumulation in the Small Intestine Contributes to Local Tissue Destruction Following Combined Radiation and Burn Injury.

Authors:  Stewart R Carter; Michael M Chen; Jessica L Palmer; Lu Wang; Luis Ramirez; Timothy P Plackett; Richard L Gamelli; Elizabeth J Kovacs
Journal:  J Burn Care Res       Date:  2016 Mar-Apr       Impact factor: 1.845

7.  Intestinal barrier disruption as a cause of mortality in combined radiation and burn injury.

Authors:  Stewart R Carter; Anita Zahs; Jessica L Palmer; Lu Wang; Luis Ramirez; Richard L Gamelli; Elizabeth J Kovacs
Journal:  Shock       Date:  2013-10       Impact factor: 3.454

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.